GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PEPTONIC medical AB (XSAT:PMED) » Definitions » Cyclically Adjusted PS Ratio

PEPTONIC medical AB (XSAT:PMED) Cyclically Adjusted PS Ratio : 0.20 (As of Jun. 08, 2024)


View and export this data going back to 2014. Start your Free Trial

What is PEPTONIC medical AB Cyclically Adjusted PS Ratio?

As of today (2024-06-08), PEPTONIC medical AB's current share price is kr0.0102. PEPTONIC medical AB's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was kr0.05. PEPTONIC medical AB's Cyclically Adjusted PS Ratio for today is 0.20.

The historical rank and industry rank for PEPTONIC medical AB's Cyclically Adjusted PS Ratio or its related term are showing as below:

XSAT:PMED' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.18   Med: 0.83   Max: 1.23
Current: 0.18

During the past years, PEPTONIC medical AB's highest Cyclically Adjusted PS Ratio was 1.23. The lowest was 0.18. And the median was 0.83.

XSAT:PMED's Cyclically Adjusted PS Ratio is ranked better than
94.35% of 743 companies
in the Drug Manufacturers industry
Industry Median: 2.05 vs XSAT:PMED: 0.18

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

PEPTONIC medical AB's adjusted revenue per share data for the three months ended in Mar. 2024 was kr0.005. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is kr0.05 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


PEPTONIC medical AB Cyclically Adjusted PS Ratio Historical Data

The historical data trend for PEPTONIC medical AB's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PEPTONIC medical AB Cyclically Adjusted PS Ratio Chart

PEPTONIC medical AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 0.80

PEPTONIC medical AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.84 1.07 1.00 0.80 0.62

Competitive Comparison of PEPTONIC medical AB's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, PEPTONIC medical AB's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PEPTONIC medical AB's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PEPTONIC medical AB's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where PEPTONIC medical AB's Cyclically Adjusted PS Ratio falls into.



PEPTONIC medical AB Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

PEPTONIC medical AB's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=0.0102/0.05
=0.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PEPTONIC medical AB's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, PEPTONIC medical AB's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.005/132.2054*132.2054
=0.005

Current CPI (Mar. 2024) = 132.2054.

PEPTONIC medical AB Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.000 100.432 0.000
201409 0.000 100.161 0.000
201412 0.000 100.225 0.000
201503 0.000 99.950 0.000
201506 0.000 99.995 0.000
201509 0.000 100.228 0.000
201512 0.000 100.276 0.000
201603 0.000 100.751 0.000
201606 0.000 101.019 0.000
201609 0.000 101.138 0.000
201612 0.000 102.022 0.000
201703 0.000 102.022 0.000
201706 0.000 102.752 0.000
201709 0.000 103.279 0.000
201712 0.000 103.793 0.000
201803 0.000 103.962 0.000
201806 0.000 104.875 0.000
201809 0.001 105.679 0.001
201812 0.001 105.912 0.001
201903 0.007 105.886 0.009
201906 0.005 106.742 0.006
201909 0.005 107.214 0.006
201912 0.001 107.766 0.001
202003 0.006 106.563 0.007
202006 0.004 107.498 0.005
202009 0.025 107.635 0.031
202012 0.019 108.296 0.023
202103 0.025 108.360 0.031
202106 0.018 108.928 0.022
202109 0.017 110.338 0.020
202112 0.014 112.486 0.016
202203 0.022 114.825 0.025
202206 0.024 118.384 0.027
202209 0.024 122.296 0.026
202212 0.020 126.365 0.021
202303 0.007 127.042 0.007
202306 0.012 129.407 0.012
202309 0.006 130.224 0.006
202312 0.003 131.912 0.003
202403 0.005 132.205 0.005

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


PEPTONIC medical AB  (XSAT:PMED) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


PEPTONIC medical AB Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of PEPTONIC medical AB's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


PEPTONIC medical AB (XSAT:PMED) Business Description

Traded in Other Exchanges
Address
Gustavslundsvägen 143, Bromma, SWE, SE-167 51
PEPTONIC medical AB is a pharmaceutical company. It is engaged in developing oxytocin-based products for the treatment of menopausal symptoms, such as vaginal atrophy and vaginal dryness. Oxytocin is for medical use and offers an alternative to estrogen and estrogen-like acting compounds for menopausal and postmenopausal women. The company is based in Sweden.

PEPTONIC medical AB (XSAT:PMED) Headlines

No Headlines